Jefferies upgrades Sumitomo Dainippon Pharma to Buy, PT $1050.00

A Jefferies analyst upgraded Sumitomo Dainippon Pharma (TYO: 4506) from Hold to Buy with a price target of $1050.00 from a prior price target of JPY830.00.
Prior to this rating, Sumitomo Dainippon Pharma had 0 buy ratings, 5 hold ratings, and 2 sell ratings.
For consensus analyst estimates and price targets on Sumitomo Dainippon Pharma, click here. For more news on Sumitomo Dainippon Pharma, click here.
Sumitomo Dainippon Pharma's stock price closed at $827.0. They are up 2.22% in the last month and down -25.8% in the last 12 months.
According to Investing Pro, Sumitomo Dainippon Pharma's fair value is $1.1K, an upside of 28.3%. Sumitomo Dainippon Pharma's fair value comes with a medium degree of uncertainty, according to InvestingPro.
Check out Sumitomo Dainippon Pharma's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or